No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹70.95Prev. Close
₹65.5Turnover(Lac.)
₹31Day's High
₹71Day's Low
₹62.7452 Week's High
₹70.852 Week's Low
₹29.33Book Value
₹21.8Face Value
₹10Mkt Cap (₹ Cr.)
166.4P/E
61.21EPS
1.07Divi. Yield
015 Aug 2025
12:00 AM
AGM
Announcement Date: 15 Aug, 2025
15 Aug 2025
12:00 AM
BookCloser
1 Jun 2026
12:00 AM
Board Meeting
Agenda : Audited Result
11 Dec 2025
12:00 AM
EGM
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 9.95 | 8.1 | 8.1 | 8.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 7.59 | -0.75 | -0.9 | -0.86 |
Net Worth | 17.54 | 7.35 | 7.2 | 7.24 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Revenue | 3.5 | 0.92 | 1.45 | 5.74 |
yoy growth (%) | 277.33 | -36.13 | -74.63 | -3.58 |
Raw materials | -2.84 | 0 | -0.32 | -4.24 |
As % of sales | 81.2 | 0 | 22.17 | 73.84 |
Employee costs | -0.21 | -0.23 | -0.06 | -0.33 |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Profit before tax | 0.2 | 0.13 | 0.08 | 0.6 |
Depreciation | -0.12 | -0.33 | -0.39 | -0.28 |
Tax paid | -0.05 | -0.03 | -0.06 | -0.19 |
Working capital | 1.37 | -1.5 | -0.84 | 0.27 |
Other operating items |
| Y/e 31 Mar | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 277.33 | -36.13 | -74.63 | -3.58 |
Op profit growth | -53.77 | -18.59 | -45.17 | 8.52 |
EBIT growth | 50.64 | 47.78 | -85.1 | 11.11 |
Net profit growth | 53.57 | 427.68 | -95.52 | 10.19 |
| Particulars (Rupees in Crores.) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|---|
Gross Sales | 8.61 | 9.24 | 10.24 | 10.46 | 10.5 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8.61 | 9.24 | 10.24 | 10.46 | 10.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.64 | 0.34 | 0.6 | 0.38 | 0.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,783.55 | 142.57 | 4,27,933.39 | 608.7 | 0.9 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,623.5 | 66.04 | 1,75,833.11 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,418.7 | 67.6 | 1,49,548.89 | 467 | 0.86 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,400.7 | 32.87 | 1,13,154.89 | 384.64 | 0.93 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,088.9 | 29.67 | 1,09,568.82 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
E D & Wholetime Director
VENKATESHWARLU PULLURU
Independent Non Exe. Director
JANARDHAN DAS KABRA
Non-Exec & Non-Independent Dir
Jivamohan Divakar Valluri
Independent Non Exe. Director
Monam Kapoor
Independent Non Exe. Director
Lakshman Samala
Non-Exec & Non-Independent Dir
GNANA PRAKASH GATTU
Independent Non Exe. Director
Mayuri Baidya
Company Sec. & Compli. Officer
Nishita Kalantri
Director
Sridevi Belide
4-4-231/1/2/ABC Inderbagh,
Sultan Bazar,
Telangana - 500095
Tel: 91-40-24757370
Website: http://www.trimurthidrugs.com
Email: info@trimurthidrugs.com
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Novelix Pharmaceuticals Limited was initially incorporated as Trimurthi Securities Limited on December 13, 1994. The name of the Company was changed from Trimurthi Securities Limited to Trimurthi Drug...
Read More
Reports by Novelix Pharmaceuticals Ltd
What is the Novelix Pharmaceuticals Ltd share price today?
What is the Market Cap of Novelix Pharmaceuticals Ltd?
What is the PE and PB ratio of Novelix Pharmaceuticals Ltd?
What is the 52 Week High and Low of Novelix Pharmaceuticals Ltd?
What is the CAGR of Novelix Pharmaceuticals Ltd?
What is the shareholding pattern of Novelix Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
